entertainment -WSS

entertainment

author：fashion 2025-09-30 23:07:24 - browse：79554

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： When waiting feels immoral: Empathy in the emergency department

hotspot

WSS

Studies point to risks of excluding people with obesity from drug trials

Study links childhood stress with decline in older age

Why health workers in Gaza are injured or die at high rates

How to ethically and practically extend health care to all

Pharmacists can make shortage drugs, but at what cost?

Beam Therapeutics to lay off 20% of its staff, re

explore

entertainment

leisure time

Medicare details structure of new drug price negotiation program

How to ethically and practically extend health care to all

Hepatitis C has a cure — but many Americans still lack access to it

Lawmakers consider Medicare pay reforms for doctors

Novavax promises a turnaround & Lilly roils the obesity market

How to ethically and practically extend health care to all

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves Sage Therapeutics’ rapid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The EU Joint Clinical Assessment needs to live up to its promise

leisure time

STAT Summit: Biotech founders on deal

Impact of Dobbs ruling felt at reproductive medicine meeting

Heart disease in astronauts blamed on cosmic radiation

Eli Lilly expects to double planned employment in Boston center

2 officers injured in shooting in Orlando, police say

HHS leader on health, climate change and biopharma emissions

hotspot

leisure time

hotspot

hotspot